Clinical trials
Recruiting Phase 1/2 trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alentis Therapeutics AG | 2 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Biolingus | 1 |
| BlossomHill Therapeutics | 1 |
| Bristol-Myers Squibb | 1 |
| D3 Bio (Wuxi) Co., Ltd | 1 |
| Dren Bio | 1 |
| Institut de Recherches Internationales Servier | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 4 |
| Lung Neoplasms | 3 |
| Colorectal Neoplasms | 2 |
| Thyroid Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Brain Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Bronchial Neoplasms | 1 |
| Bulbo-Spinal Atrophy, X-Linked | 1 |
| Carcinoma | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.